Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
Más filtros










Intervalo de año de publicación
1.
J Assist Reprod Genet ; 40(10): 2453-2461, 2023 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-37668858

RESUMEN

PURPOSE: One of the most common causes of infertility in adult women is polycystic ovary syndrome (PCOS) which has been identified with symptoms such as chronic hyperandrogenism, anovulation, and polycystic ovaries. Adiponectin modulates steroidogenesis and the expression of ovulation-related genes. Herein, we assessed the effect of AdipoRon (adiponectin agonist) in the PCOS model mice. METHODS: The PCOS model was induced with letrozole in the adult female mice and the animals received intraperitoneal injection of AdipoRon (5 mg/kg) for 10 days. Expression of CYP11A, CYP17A, and CYP19A genes, StAR protein, and histomorphology of the ovary were evaluated using real-time RT-PCR, western blotting, and histochemistry methods, respectively. RESULTS: Although administration of letrozole caused an increase in the expression of CYP11A, CYP17A, and StAR and a decrease in the CYP19A1 expression, injection of AdipoRon reversed these changes. Moreover, AdipoRon treatment resulted in an improvement of folliculogenesis and a reduction of cysts compared to the letrozole-treated mice. CONCLUSION: It is likely that AdipoRon has protective effects on the PCOS through modulation of cytochrome P450-related genes and steroidogenesis but needs further study to be sure.


Asunto(s)
Síndrome del Ovario Poliquístico , Femenino , Animales , Ratones , Humanos , Síndrome del Ovario Poliquístico/tratamiento farmacológico , Síndrome del Ovario Poliquístico/genética , Adiponectina , Letrozol , Factores de Transcripción , Expresión Génica
2.
Hum Fertil (Camb) ; 26(6): 1408-1416, 2023 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-37469268

RESUMEN

Conventional sperm selection based on motility and morphology fails to provide detailed information on sperm functional and molecular status. Magnetic-activated cell sorting (MACS) protocol aims to optimize this process by selecting apoptotic sperm cells. Phospholipase C zeta-1 (PLCz1) is a physiological stimulus for oocyte activation and early embryonic development. The purpose of this study was to examine seminal parameters, DNA fragmentation index (DFI), and PLCz1 expression levels in MACS-DGC sorted specimens (DFI > 30%) and assess early development in resulting embryos. Semen specimens from 60 patients diagnosed with male factor infertility were collected and processed by either density gradient centrifugation (DGC) or MACS-DGC protocols. Pre and post-preparation analysis was performed. PLCz1 expression was assessed using the RT-PCR method. Retrieved eggs from their partners were divided into two groups in which they were injected with different sorted sperm. The fertilization rate and embryonic development were evaluated. While sperm's progressive motility and morphology significantly improved, there was a substantial decline in DFI following MACS-DGC. Fertilization rates were almost the same between the groups, and the latter resulted in remarkably more top-quality embryos and more blastocysts. PLCz1 expression was considerably higher in the MACS-DGC group. By eliminating apoptotic cells, the MACS-DGC technique could sort highly PLCz1-expressed sperm, optimize sperm selection in individuals with elevated DFI, development of resulting embryos.


Asunto(s)
Infertilidad Masculina , Semen , Embarazo , Femenino , Humanos , Masculino , Infertilidad Masculina/metabolismo , Espermatozoides/metabolismo , Fragmentación del ADN , ADN/metabolismo , Blastocisto
3.
Zygote ; 31(2): 111-122, 2023 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-36617989

RESUMEN

Although the role of myo-inositol (MYO) in promoting the oocyte quality of PCOS patients has been documented in human studies; the cellular effects of this supplement on oocytes have not been directly examined due to ethical limitations. In the first phase of this study, MYO dosimetry was carried out simultaneously with the PCOS model development. An effective dose was obtained following the assessment of fasting insulin and testosterone levels using ELISA and ovarian morphology appraisal by histopathology. In the second phase, following the continuous administration of the effective dose of MYO and dehydroepiandrosterone (DHEA), cellular evaluation was performed. The quality of oocytes from superovulation was analyzed by examining maturity and normal morphology percentage using a stereomicroscope, intracellular reactive oxygen species (ROS) and glutathione (GSH) levels using fluorometry, and ATP count evaluation using ELISA. The results revealed that, among the four different MYO concentrations, the 0.36 mg/g dose compared with the DHEA group reduced testosterone levels and large atretic antral follicles (LAtAnF) diameter. This dose also increased the corpus luteum count and the granulosa:theca (G/T)layer thickness ratio in antral follicles. Furthermore, this dose increased mature oocytes and normal morphology percentage, ATP count, and GSH levels; however, it decreased ROS levels in mature oocytes. Our findings provide the grounds for further cellular and molecular studies on the PCOS mouse model, suggesting that the improvement in mitochondrial function and its antioxidant properties is probably one of the mechanisms by which MYO increases oocyte quality.


Asunto(s)
Ácido Fólico , Síndrome del Ovario Poliquístico , Femenino , Animales , Ratones , Humanos , Ácido Fólico/farmacología , Especies Reactivas de Oxígeno , Inositol/farmacología , Oocitos , Glutatión , Testosterona/farmacología , Deshidroepiandrosterona/farmacología , Adenosina Trifosfato/farmacología
4.
Int J Reprod Biomed ; 19(7): 589-598, 2021 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-34458667

RESUMEN

BACKGROUND: Cerium dioxide nanoparticles (CNPs) due to the antidiabetic and antioxidant activities are proposed for the treatment of oxidative stress-associated diseases. OBJECTIVE: To examine the impact of CNPs on hyperglycemia-induced apoptosis and oxidative stress in the testis of diabetic rats. MATERIALS AND METHODS: Twenty-four male rats were divided into four groups (n = 6/each) as diabetic rats, CNPs group, diabetic + CNPs rats, and controls. The control group was fed only mouse food and water. Rats became diabetic through receiving streptozotocin (STZ) 60 mg/kg. CNPs were given to the rats at a dose of 30 mg/kg daily for 2 wk. Malondialdehyde and total thiol group (TTG) levels were measured using spectrofluorometer. Expression of b-cell lymphoma protein 2-associated X protein (BAX) and b-cell lymphoma protein 2 (Bcl-2) were investigated using quantitative real-time polymerase chain reaction. Western blot analysis was used to examine caspase 3 protein levels. RESULTS: The content of malondialdehyde significantly increased in the STZ-diabetic rats, while TTG levels demonstrated a remarkable decrease. Caspase-3, BAX, and BAX/Bcl-2 mRNA ratio raised significantly in the STZ-diabetic rats. On the other hand, Bcl-2 mRNA levels reduced in the testis of diabetic rats (p = 0.006). Intervention with CNPs caused a substantial increase in the TTG levels, while the malondialdehyde contents, caspase-3, BAX levels, as well as BAX/Bcl-2 mRNA ratio were considerably decreased following CNPs treatment. Administration of CNPs increased mRNA levels of Bcl-2 (p < 0.0001). CONCLUSION: CNPs treatment attenuates testicular apoptosis and oxidative stress induced by diabetes. This nanoparticle might be suggested for the treatment of diabetes-associated reproductive disorders.

5.
Arch. endocrinol. metab. (Online) ; 65(1): 60-66, Jan.-Feb. 2021. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1152880

RESUMEN

ABSTRACT Objective: A disintegrin and metalloproteinase with thrombospondin motifs 4 (ADAMTS-4) and ADAMTS-5 normal expression levels are essential for ovulation and subsequent fertilization. The objective of the present study was to assess expression pattern of these genes in cumulus cells (CCs) taken from patients with polycystic ovary syndrome (PCOS) and to investigate any possible relationship with the oocyte quality. Subjects and methods: ADAMTS-4 and -5 expression levels within CCs containing oocytes at the metaphase II (MII) and germinal vesicle (GV) stages, taken from 35 patients with PCOS and 35 women with normal ovarian function, were investigated using RT-qPCR. Moreover, possible correlations between ADAMTS-4, ADAMTS-5, and progesterone receptors (PRs) expression as well as oocyte quality were evaluated. Results: ADAMTS-4 and -5 expression levels were dramatically diminished in the CCs of the PCOS patients when compared to the controls. ADAMTS-4 and -5 expression levels were correlated with each other and with the oocyte quality. Furthermore, lower expression levels of ADAMTS-4 and -5 in the PCOS patients were strongly correlated with the diminished PRs expression levels. Conclusions: Downregulation of ADAMTS-4 and -5 in the human CCs of the PCOS patients correlated with the decline in the PRs expression, and impaired oocyte quality may cause lower oocyte recovery, maturation, and fertilization rate.


Asunto(s)
Femenino , Humanos , Oocitos , Síndrome del Ovario Poliquístico , Síndrome del Ovario Poliquístico/genética , Proteína ADAMTS4/genética , Proteína ADAMTS5/genética , Regulación hacia Abajo
6.
Arch Endocrinol Metab ; 65(1): 60-66, 2021 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-33444494

RESUMEN

OBJECTIVE: A disintegrin and metalloproteinase with thrombospondin motifs 4 (ADAMTS-4) and ADAMTS-5 normal expression levels are essential for ovulation and subsequent fertilization. The objective of the present study was to assess expression pattern of these genes in cumulus cells (CCs) taken from patients with polycystic ovary syndrome (PCOS) and to investigate any possible relationship with the oocyte quality. METHODS: ADAMTS-4 and -5 expression levels within CCs containing oocytes at the metaphase II (MII) and germinal vesicle (GV) stages, taken from 35 patients with PCOS and 35 women with normal ovarian function, were investigated using RT-qPCR. Moreover, possible correlations between ADAMTS-4, ADAMTS-5, and progesterone receptors (PRs) expression as well as oocyte quality were evaluated. RESULTS: ADAMTS-4 and -5 expression levels were dramatically diminished in the CCs of the PCOS patients when compared to the controls. ADAMTS-4 and -5 expression levels were correlated with each other and with the oocyte quality. Furthermore, lower expression levels of ADAMTS-4 and -5 in the PCOS patients were strongly correlated with the diminished PRs expression levels. CONCLUSION: Downregulation of ADAMTS-4 and -5 in the human CCs of the PCOS patients correlated with the decline in the PRs expression, and impaired oocyte quality may cause lower oocyte recovery, maturation, and fertilization rate.


Asunto(s)
Proteína ADAMTS4/genética , Proteína ADAMTS5/genética , Oocitos , Síndrome del Ovario Poliquístico , Regulación hacia Abajo , Femenino , Humanos , Síndrome del Ovario Poliquístico/genética
7.
Acta Histochem ; 122(5): 151556, 2020 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-32622423

RESUMEN

Asherman's syndrome (AS) is an endometrial damage that results in infertility in women. Although stem cell therapy has been introduced as a potential treatment for this syndrome, its use in clinical settings remains challenging because of the likelihood of contamination and cell differentiation. Herein, we investigated the effects of adipose-derived stromal vascular fraction (SVF) transplantation on proliferation and angiogenesis in the endometrium in an AS model. The AS model was induced using scratch method in adult male Wistar rats, and SVF (5 × 10 (Simsir et al., 2019) cells) was locally administered into the damaged horns. Two weeks after cell transplantation, endometrial thickness, fibrosis, and expression of vascular endothelial growth factor (VEGF) were assessed by Hematoxylin & Eosin, Masson's trichrome, and immunofluorescence staining, respectively. We found thin endometrium, increased fibrosis, and decreased VEGF following AS induction all of which were reversed after SVF transplantation. We concluded that the local injection of SVF may serve as an effective alternative therapy for AS.


Asunto(s)
Tejido Adiposo/citología , Endometrio/metabolismo , Ginatresia/metabolismo , Células del Estroma/microbiología , Factor A de Crecimiento Endotelial Vascular/metabolismo , Animales , Diferenciación Celular/fisiología , Femenino , Ginatresia/terapia , Masculino , Ratas Wistar , Células del Estroma/metabolismo , Células del Estroma/patología
8.
J Assist Reprod Genet ; 37(8): 1861-1868, 2020 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-32535814

RESUMEN

PURPOSE: Cell therapy is a promising strategy for the treatment of Asherman's syndrome (AS), but the origin of these cells and injection route influence the therapeutic effect and complications of cell therapy. Herein, we compared the effects of systemic or local intrauterine injection of bone marrow or adipose-derived mesenchymal stem cells (BMSCs/AMSCs) on the endometrium in a rat model of AS. METHODS: After induction of AS in adult Wistar rats, the CM-Dil-positive BMSCs or AMSCs were injected either locally or intravenously. After 3 weeks, endometrial thickness, collagen deposition, cell migration, and VEGF expression were evaluated using histochemistry/immunofluorescence studies. RESULTS: In all stem cell-treated groups, an ameliorative effect on the damaged endometrium was noted. Collagen deposition diminished in both groups (IV and local injection) compared to the AS model. In rats injected locally with MSC, fibrosis decreased compared to the other groups. Moreover, endometrial thickness increased in the groups that received local injection of BMSCs and AMSCs more than the IV-transplanted AMSCs group. Immunofluorescent staining demonstrated that although the systemic transplantation of BMSCs was more effective than the other groups on VEGF expression, it led to the lowest number of CM-Dil+ stem cells in the damaged endometrium. CONCLUSION: Stem cell transplantation may reconstruct the damaged endometrium, but it is recommended to select the most effective stem cells and injection route. Because the removal of the fibrosis and the replacement of the epithelia cells is an effective therapeutic strategy for AS, in this study, we conclude that the local injection of AMSCs is more appropriate than BMSCs to treat AS.


Asunto(s)
Tratamiento Basado en Trasplante de Células y Tejidos , Ginatresia/terapia , Trasplante de Células Madre Mesenquimatosas , Factor A de Crecimiento Endotelial Vascular/genética , Tejido Adiposo/citología , Tejido Adiposo/trasplante , Animales , Células de la Médula Ósea/citología , Modelos Animales de Enfermedad , Femenino , Regulación del Desarrollo de la Expresión Génica/genética , Ginatresia/genética , Ginatresia/patología , Humanos , Células Madre Mesenquimatosas/citología , Ratas , Medicina Regenerativa
9.
Cell Biol Int ; 44(8): 1577-1587, 2020 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-32339379

RESUMEN

Adaptor protein containing a PH domain, PTB domain and leucine zipper motif 1 (APPL1) plays a central role as the main contributing factor in the adiponectin and insulin signaling. This review aims to discuss previous and recent findings concerning the role of APPL1 in the polycystic ovary syndrome (PCOS) patients with conclusions regarding more efficient therapeutic approaches. A literature review was performed in PubMed, Web of Science, ScienceDirect, Scopus, and Google Scholar from August 1999 to May 2020. This study reveals that APPL1 has a key role in adiponectin, insulin, and follicle-stimulating hormone signaling pathways occurring within the ovaries. Recent studies in mouse model systems have indicated that APPL1 can prevent diabetes, endothelial disorders, and insulin resistance. In contrast, APPL1 deficiency can lead to the metabolic and vascular disorders. APPL1 due to its potential roles in different signaling pathways might be suggested as a novel diagnostic and therapeutic option for prediction of ovarian dysfunctions and treatment of reproductive disorders, especially PCOS.


Asunto(s)
Proteínas Adaptadoras Transductoras de Señales/fisiología , Adiponectina/metabolismo , Insulina/fisiología , Síndrome del Ovario Poliquístico/metabolismo , Animales , Endometrio/metabolismo , Femenino , Humanos , Ratones , Folículo Ovárico/crecimiento & desarrollo , Ovario/metabolismo , Receptor de Insulina/metabolismo , Transducción de Señal , Útero/metabolismo
10.
Life Sci ; 249: 117482, 2020 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-32135186

RESUMEN

AIMS: Improving the environment of the injured area and the preconditioning of mesenchymal stem cells (MSCs) are promising approaches to optimize the therapeutic properties of transplanted MSCs. Herein we investigated the synergistic effects of treadmill exercise and dimethyloxalylglycine (DMOG)-preconditioned stem cells in an Alzheimer's disease (AD) animal model. MATERIALS AND METHODS: The MSCs were treated with DMOG for 24 h and transplanted in the AD model intravenously. In addition to cell transplantation, the rats went on treadmill exercise for one month. Memory function, BDNF expression, neurogenesis, apoptosis, and antioxidant capacity were assessed using shuttle box and Morris water maze tasks, ELISA, immunohistochemistry, western blot, and biochemical methods. KEY FINDINGS: Transplantation of DMOG-treated cells caused a memory improvement compared to the AD group via an increase in neurogenesis and expression of nestin, Sox-2, and NeuroD. Moreover, the injection of preconditioned cells was more effective in increasing the total antioxidant capacity and the BDNF level and decreasing the MDA and caspase-3 than the non-treated cells. Treadmill exercise improved spatial memory and learning through an increase in BDNF and neurogenesis. Finally, treadmill exercise and transplantation of the treated cells together had the most neuroprotective effects. SIGNIFICANCE: It seems that the transplantation of DMOG-treated cells besides exercise may have protective effects in the AD model via an increase in BDNF, antioxidants, and neurogenesis and a decrease in apoptosis.


Asunto(s)
Péptidos beta-Amiloides/toxicidad , Memoria , Neurogénesis , Condicionamiento Físico Animal , Células Madre/citología , Animales , Masculino , Ratas , Ratas Wistar
11.
Physiol Behav ; 199: 265-272, 2019 02 01.
Artículo en Inglés | MEDLINE | ID: mdl-30500334

RESUMEN

Mesenchymal stem cell (MSC) transplantation therapy has been proposed as a promising approach for the treatment of neurodegenerative disease. Chemical and pharmacological preconditioning before transplantation could optimize the therapeutic properties of transplanted MSCs. In this study, we hypothesized that preconditioning treatment with a prolyl hydroxylase inhibitor, dimethyloxalylglycine (DMOG), will increase MSC efficacy and paracrine effects in an amyloid-ß (Aß)-injected Alzheimer rat model. MSCs were incubated in different concentrations of DMOG for 24 h. Cell viability, migration, and antioxidant capacity was assessed in DMOG-treated and non-treated MSCs before transplantation into Aß-injected rats. In vitro analysis revealed that DMOG treatment increased cell viability, migration, and expression of CXCR4, CCR2, Nrf2, and HIF-1α in the MSCs. Our in vivo results show that DMOG preconditioning enhances a MSC-mediated rescue of learning and memory function in Aß-injected rats. Furthermore, we found an increased level of BDNF and total antioxidant capacity in the hippocampus of Aß-injected rats following transplantation of preconditioned relative to untreated MSCs. Our results suggest that preconditioning MSCs with DMOG before transplantation may enhance the efficacy of stem cell based therapy in neurodegenerative disease.


Asunto(s)
Enfermedad de Alzheimer/terapia , Aminoácidos Dicarboxílicos/uso terapéutico , Supervivencia Celular/efectos de los fármacos , Trasplante de Células Madre Mesenquimatosas/métodos , Células Madre Mesenquimatosas/efectos de los fármacos , Enfermedad de Alzheimer/inducido químicamente , Aminoácidos Dicarboxílicos/farmacología , Péptidos beta-Amiloides , Animales , Modelos Animales de Enfermedad
12.
Arch Gynecol Obstet ; 299(1): 277-286, 2019 01.
Artículo en Inglés | MEDLINE | ID: mdl-30446843

RESUMEN

PURPOSE: ADAMTS-1 and 9 play a crucial role in the ovulation and their altered levels may play a role in the pathogenesis of polycystic ovary syndrome (PCOS). The aim of this study was to assess ADAMTS-1 and 9 expression and their correlation with the oocyte quality and maturity in the cumulus cells (CCs) of PCOS patients and normovulatory women during an IVF procedure. METHODS: Expression of ADAMTS-1 and 9 and progesterone receptors (PRs) in the CCs containing MII and germinal vesicle (GV) oocytes of 37 PCOS patients and 37 women with normal ovulatory function who underwent IVF treatment was evaluated using qRT-PCR. Moreover, correlation between ADAMTS-1 and 9 expression and oocyte quality were also investigated. RESULTS: mRNA expression levels of ADAMTS-1 and ADAMTS-9 were significantly reduced in the women with PCOS compared to the normovulatory women. ADAMTS-1 and ADAMTS-9 mRNA expression levels in the CCs showed a considerable correlation. Lower expression levels of ADAMTS-1 and ADAMTS-9 in PCOS patients were strongly correlated with diminished oocyte maturation. There was a remarkable association between ADAMTS-1 and ADAMTS-9 mRNA expression levels and oocyte quality. PRs (PRA and PRB) were dramatically decreased in PCOS patients when compared with the control group. CONCLUSIONS: The results of the present study indicated that ADAMTS-1 and ADAMTS-9 as well as PRs are downregulated in the human CCs in PCOS patients, which could be associated with impaired oocyte maturation and may result in a lower oocyte recovery and oocyte maturity rates, as well as lower fertilization rate.


Asunto(s)
Proteína ADAMTS1/genética , Proteína ADAMTS9/genética , Células del Cúmulo/metabolismo , Oocitos/patología , Síndrome del Ovario Poliquístico/metabolismo , Reacción en Cadena de la Polimerasa/métodos , Receptores de Progesterona/metabolismo , Proteína ADAMTS1/metabolismo , Proteína ADAMTS9/metabolismo , Adulto , Femenino , Humanos , Recuperación del Oocito , Oocitos/metabolismo , Oogénesis , Ovulación , Síndrome del Ovario Poliquístico/genética , Síndrome del Ovario Poliquístico/patología , Receptores de Progesterona/genética
13.
Andrologia ; 50(9): e13089, 2018 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-30022501

RESUMEN

Cerium oxide nanoparticles (CNPs) as an antioxidant have been used frequently to attenuate hyperglycaemia oxidative damage in different organs. We investigated the impact CNPs on the qualitative and quantitative sperm parameters, spermatogenesis and NFE2-related factor 2 (Nrf2) expression as a major contributor of antioxidant defence in the male diabetic rats. Twenty-four male rats were divided into four groups. Controls received only mouse food and water. Second group were treated with CNPs (30 mg kg-1  day-1 ) for 2 weeks. Rats in third group received streptozotocin (STZ) (60 mg/kg). In fourth group, animals became diabetic and received CNPs (30 mg kg-1  day-1 ) for 2 weeks. The results showed a significant abnormality in the sperm parameters and histopathological patterns of testes in the diabetic group compared to the control group and CNPs treatment significantly improved all testicular parameters. Following CNPs administration, sperm DNA fragmentation significantly reduced in the STZ-treated rats. Moreover, after CNPs intake in the STZ-treated rats, Nfr2 expression levels increased significantly. Overall, CNPs administration on the diabetic rates can attenuate detrimental effects of diabetes on the sperm potential fertility, sperm parameters, DNA integrity and Nrf2 expression levels. This study gives a future prospect to determine the role of CNPs in the context of diabetes.


Asunto(s)
Cerio/uso terapéutico , Complicaciones de la Diabetes/tratamiento farmacológico , Espermatozoides/efectos de los fármacos , Enfermedades Testiculares/tratamiento farmacológico , Testículo/efectos de los fármacos , Animales , Cerio/farmacología , Fragmentación del ADN/efectos de los fármacos , Complicaciones de la Diabetes/sangre , Complicaciones de la Diabetes/patología , Evaluación Preclínica de Medicamentos , Hormonas/sangre , Masculino , Factor 2 Relacionado con NF-E2/metabolismo , Nanopartículas , Ratas Wistar , Espermatogénesis/efectos de los fármacos , Enfermedades Testiculares/sangre , Enfermedades Testiculares/patología , Testículo/metabolismo , Testículo/patología
14.
Can J Physiol Pharmacol ; 96(9): 963-969, 2018 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-29894645

RESUMEN

CeO2 nanoparticles (CNPs) as effective ROS scavengers exhibit potent antioxidant activity. In this study the effect of CNPs investigated was on HO-1, NQO1, and GCLC expression in the streptozotocin (STZ)-induced diabetic rats. Twenty-four male Wistar rats were divided into 4 groups: controls did not receive any treatment; diabetic rats received STZ (60 mg/kg daily); CNPs group received CNPs 30 mg/kg daily for 2 weeks; and rats in STZ + CNPs group received CNPs 30 mg/kg daily for 2 weeks following STZ injection. Oxidative stress was evaluated by measurement of total antioxidant capacity (TAC) and total oxidative status (TOS levels). HO-1, NQO1, and GCLC expression was measured using quantitative real-time PCR. Following STZ injection, significant lower levels of TAC and higher levels of TOS were observed. CNPs could alleviate deleterious effects of diabetes through the enhancement of TAC levels and a significant decline in TOS levels. HO-1, NQO1, and GCLC expression in the diabetic rats were lower than controls. HO-1, NQO1, and GCLC was upregulated in the diabetic rats treated with CNPs. There were significant correlations between NQO1 and GCLC, NQO1 and HO-1, and between HO-1 and GCLC expression. Moreover, Nrf2 was associated with NQO1, GCLC, and HO-1 expression. CNPs as Nrf2 upregulator confer protection against oxidative stress in the testes of STZ-induced diabetic rats by upregulating HO-1, GCLC, and NQO1 cytoprotective genes.


Asunto(s)
Cerio/farmacología , Diabetes Mellitus Experimental/genética , Glutamato-Cisteína Ligasa/genética , Hemo-Oxigenasa 1/genética , NAD(P)H Deshidrogenasa (Quinona)/genética , Nanopartículas , Testículo/efectos de los fármacos , Animales , Cerio/química , Diabetes Mellitus Experimental/enzimología , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Masculino , Estrés Oxidativo/efectos de los fármacos , Ratas , Ratas Wistar , Testículo/metabolismo
15.
J Assist Reprod Genet ; 33(1): 101-10, 2016 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-26631404

RESUMEN

PURPOSE: The purpose of the study was to investigate changes in adiponectin system expression in granulosa cells (GCs) and high molecular weight adiponectin levels in serum and follicular fluid (FF) of 40 women with polycystic ovary syndrome (PCOS) compared to those in 40 women with normal ovary function. METHODS: Adiponectin (Adipo), adiponectin receptor 1 (AdipoR1), and adiponectin receptor 2 (AdipoR2) messenger RNA (mRNA) expression levels were measured using quantitative real-time polymerase chain reaction (qRT-PCR). High molecular weight (HMW) adiponectin protein concentration was evaluated by ELISA method. Data were analyzed using Student's t test and one-way ANOVA in SPSS 21 software. At oocyte retrieval, FF was aspirated and GCs were obtained from a pooled collection of FF per each patient. RESULTS: PCR results showed expression of adiponectin, AdipoR1, AdipoR2, follicle-stimulating hormone receptor (FSHR), and luteinizing hormone receptor (LHR) in GCs. After controlling body mass index (BMI) values, qRT-PCR demonstrated a decreased expression of adiponectin system in GCs of PCOS patients compared to those in controls (p = 0.001). There was a strong positive correlation among AdipoR1 and AdipoR2 expression and also among FSH and LH receptor expression. (Both r = 0.8, p = 0.001). There were low levels of high molecular weight adiponectin in the serum of PCOS patients with controlled ovarian hyperstimulation (30.19 ± 4.3 ng/ml) compared to the controls (48.47 ± 5.9 ng/ml) and in the FF of PCOS patients with controlled ovarian hyperstimulation (7.86 ± 1.44 ng/ml) compared to the controls (14.22 ± 2.01 ng/ml; p = 0.02). CONCLUSIONS: Lower expression of adiponectin and its receptors in GCs might be an important manifestation in gonadotropin-stimulated PCOS patients which could influence the physiologic adiponectin roles such as interaction with insulin and LH in induction of GC gene expression.


Asunto(s)
Adiponectina/sangre , Células de la Granulosa/metabolismo , Síndrome del Ovario Poliquístico/genética , Receptores de Adiponectina/genética , Adiponectina/biosíntesis , Adulto , Índice de Masa Corporal , Femenino , Fertilización In Vitro , Hormona Folículo Estimulante/sangre , Líquido Folicular/metabolismo , Regulación del Desarrollo de la Expresión Génica , Humanos , Síndrome del Ovario Poliquístico/sangre , Síndrome del Ovario Poliquístico/patología , Progesterona/sangre , Receptores de Adiponectina/sangre , Receptores de HL/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...